A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
Public ClinicalTrials.gov record NCT01886820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01886820
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Navidea Biopharmaceuticals
- Industry
- Enrollment
- 290 participants
Conditions and interventions
Conditions
Interventions
- [18F]NAV4694 Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2013
- Primary completion
- May 31, 2018
- Completion
- Aug 31, 2018
- Last update posted
- Jul 25, 2017
2013 – 2018
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Sun Health Research Institute | Sun City | Arizona | 85351 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| Neuropsychiatric Research Center of Southwest Florida | Fort Myers | Florida | 33912 | — |
| Mount Sinai Medical Center of Florida | Miami Beach | Florida | 33140 | — |
| Galiz Research | Miami Springs | Florida | 33166 | — |
| Compass Research | Orlando | Florida | 32806 | — |
| Physicians Care Clinical Research | Sarasota | Florida | 34239 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Southern Illinois University School of Medicine | Springfield | Illinois | 62702 | — |
| Biomedical Research Foundation | Shreveport | Louisiana | 71103 | — |
| Las Vegas Radiology | Las Vegas | Nevada | 89113 | — |
| Albert Einstein College of Medicine | The Bronx | New York | 10461 | — |
| The University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27559 | — |
| Wake Forest Baptist Health-Gerontology | Winston-Salem | North Carolina | 27157 | — |
| Valley Medical Center | Centerville | Ohio | 45459 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01886820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 25, 2017 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01886820 live on ClinicalTrials.gov.